Exploring the importance of zinc binding and steric/hydrophobic factors in novel HCV replication inhibitors

Bioorganic & Medicinal Chemistry Letters
2016.0

Abstract

Several novel compounds have been identified that inhibit the replication of hepatitis C virus in a replicon assay with EC50 values as low as 0.6 μM. Lead compounds were modified to investigate the possible role that zinc binding may play in inhibitor efficacy. In addition, the structure-activity relationship was explored to increase inhibitor efficacy and possibly identify favorable interactions within the currently unknown inhibitor binding pocket. The rationale for inhibitor design and biological results are presented herein.

Knowledge Graph

Similar Paper

Exploring the importance of zinc binding and steric/hydrophobic factors in novel HCV replication inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Synthesis and evaluation of novel potent HCV NS5A inhibitors
Bioorganic & Medicinal Chemistry Letters 2012.0
Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
Bioorganic & Medicinal Chemistry Letters 2008.0
4-(1,1-Dioxo-1,4-dihydro-1λ6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase
Bioorganic & Medicinal Chemistry Letters 2008.0
Hydroxamic Acids Block Replication of Hepatitis C Virus
Journal of Medicinal Chemistry 2015.0
Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors
European Journal of Medicinal Chemistry 2017.0
Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus
European Journal of Medicinal Chemistry 2022.0
The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus
Bioorganic & Medicinal Chemistry 2012.0
In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase
European Journal of Medicinal Chemistry 2017.0
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase
Bioorganic & Medicinal Chemistry Letters 2008.0